Finland - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Finland Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry grew 3.3% year on year. With $174,819,523.26 Million PPP in 2019, the country was number 25 comparing other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry. Finland is overtaken by Portugal, which was ranked number 24 at $178,795,494.19 Million PPP and is followed by Czech Republic at $108,981,820.05 Million PPP. United States topped the ranking with $70,565,318,932.39 Million PPP in 2019, that is +3.3% versus 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +43.9% per year, while Lithuania recorded the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 174,819,523.26 |
| 2018 | 171,372,001.30 |
| 2017 | 170,933,042.30 |
| 2016 | 162,886,104.03 |
| 2015 | 143,250,044.51 |
How does Finland rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 24 |
#24
Portugal
|
178,795,494.19 | 2019 | +3.3 % | +6.6 % | View data | |
| 25 |
#25
Finland
|
174,819,523.26 | 2019 | +2.0 % | +3.3 % | View data | |
| 26 |
#26
Czech Republic
|
108,981,820.05 | 2019 | -1.9 % | +5.2 % | View data | |